Why is Krebs Biochem falling/rising?

As of 17-Jul, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 81.23, reflecting a decrease of Rs 2.65 or 3.16%. The stock has underperformed its sector by 3.58% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 3.47% during this period. Additionally, the stock opened with a loss of 2% today and reached an intraday low of Rs 81.15. Over the past week, Krebs Biochem has seen a return of -1.25%, and its performance over the last month has been particularly poor, with a decline of 11.55%. The company has reported negative results for the last two consecutive quarters, contributing to a weak long-term fundamental strength characterized by a negative book value and a high debt-to-equity ratio.
In the broader market context, Krebs Biochem's performance contrasts sharply with the Sensex, which has shown a slight decline of 1.12% over the past week. The stock has consistently underperformed against the benchmark over the last three years, with a return of -18.85% compared to the Sensex's gain of 53.01%. This persistent underperformance, coupled with the company's weak financial indicators, such as a negative EBITDA and declining profits, has led to a lack of investor confidence, further exacerbating the stock's downward trajectory.